Thank you for visiting IMB Dx, Innovative Healthcare Company through Blood-based Early Detection of Cancer.

 

IMB Dx is a liquid biopsy company, connecting physicians and their patients to the latest cancer diagnostics approaches and making precision medicine a reality.



Our liquid biopsy test is the leading platform for comprehensive somatic mutation and empowers physicians to make more precise clinical decisions for each patient.
This information highlights the clinical significance of the patient’s tumor profile in order to increase potential treatment options.


By analyzing ctDNA with our comprehensive genomic profiling approach, IMB Dx is committed to bringing you the most up-to-date recommendations, backed by reliable evidence-based science.


Thank you

Peter Moon

Thank you for visiting IMB Dx, Innovative Healthcare
Company through Blood-based Early Detection of Cancer.

 

IMB Dx is a liquid biopsy company, connecting physicians and their patients to the latest cancer diagnostics approaches and making precision medicine a reality.


Our liquid biopsy test is the leading platform for comprehensive somatic mutation and empowers physicians to make more precise clinical decisions for each patient.
This information highlights the clinical significance of the patient’s tumor profile in order to increase potential treatment options.

By analyzing ctDNA with our comprehensive genomic profiling approach, IMB Dx is committed to bringing you the most up-to-date recommendations, backed by reliable evidence-based science.

Thank you


Peter Moon

IMB Dx

Address : 20F, Bldg A, BYC Highcity, 131, Gasan digital 1-ro, Geumcheon-gu, Seoul, 08506, Korea

Tel : +82-26951-2906  ㅣ  Fax : +82-26947-3705  ㅣ  E-mail : info@imbdx.com

Copyright ⓒ IMB Dx, lnc.  All rights reserved.